PROVIDER PROFILE · NPI 1366526733

Dean Nasser

PRACTICETEXAS INSTITUTE OF CHEST-SLEEP DISORDERS.See all providers at this practice →

Internal MedicineHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$41K

Distinct drugs

Brand share

84.0%

Top prescribed drugs

Umeclidinium Brm/Vilanterol Tr30 claims

Albuterol Sulfate19 claims

Budesonide/Glycopyr/Formoterol19 claims

Levocetirizine Dihydrochloride15 claims

Fluticasone/Umeclidin/Vilanter11 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$35

Payment records

By payment type

Food and Beverage$35

REFERRAL NETWORK

Where Dean Nasser's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CHCA BAYSHORE LP	28	67
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	12	41

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Alex Lechin Internal Medicine · Houston, TX	33	157
CHCA BAYSHORE LP	12	30
SHAHAR, JULIO	11	23

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history